Subscribe to RSS - osa


Sleep apnea sufferers downplay treatment, Philips survey finds


AMSTERDAM, the Netherlands – Thirty percent of people with sleep apnea somewhat or completely agree that they don’t think it’s necessary to be treated for sleep apnea, according to a

NY railway starts OSA program


GLENDALE, N.Y. – New York & Atlantic Railway launched an Obstructive Sleep Apnea program on Jan. 23, screening nearly 40 NYA locomotive engineers and conductors in New York City and Long Island, N.Y.

ASAA receives funding for study


WASHINGTON – The Patient-Centered Outcomes Research Institute Board of Governors has approved a three-year, $2.5 million demonstration project called the O2VERLAP Study, the American Sleep Apnea Association (ASAA) has announced.

No link between CPAP and glycemic control, study says


MELBOURNE, Australia – CPAP therapy may not improve glycemic control for people with Type 2 diabetes and obstructive sleep apnea after all, according to a new study in the American Journal of Respiratory and Critical Care Medicine.

Sleep Specialists device used in OSA study


BALA CYNWYD, Pa. – Sleep Specialists’ Zzoma Positional Device was used in a study researching cost effectiveness of positional therapy to help treat obstructive sleep apnea (OSA), the medical device company announced yesterday.

Study promotes primary care for sleep apnea patients


LLEIDA, Spain– A new study has found that monitoring patients with obstructive sleep apnea syndrome (OSA) in a primary care setting is equally effective as monitoring them in sleep units.

In brief: MACs miss standards, health spending stays low


BALTIMORE – Medicare Administrative Contractors (MACs) failed to meet one-quarter of CMS’s performance standards, according to a new report from the Office of Inspector General (OIG).

Contractor clarifies respiratory policy


WASHINGTON – Medicare does not reimburse for home oxygen used specifically to treat obstructive sleep apnea (OSA) because it is not the primary treatment for that disease, even if beneficiaries cannot tolerate PAP devices, CGS Associates said in a recent FAQ sent to providers.

Theravent hits milestone in sleep disorder treatment


SAN JOSE, Calif. – Theravent’s sleep apnea treatments have now been used for more than 4.5 million nights, the company announced Oct. 29.

OSA could lead to more heart disease in women, study says


LOS ANGELES – Obstructive sleep apnea (OSA) disrupts body functions controlling blood pressure, heart rate and sweating, more so in women than in men, according to a new study from the University of California, Los Angeles, School of Nursing.